B6E Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Swedish Orphan Biovitrum AB (publ)

Watchlist Manager

Watchlist

Price: 38.38 EUR 1.32%

Market Cap: €8.3B

S	Swedish Orphan Biovitrum AB (publ) XMUN:B6E	SE
	Cumberland Pharmaceuticals Inc NASDAQ:CPIX	US
K	Kosmos Energy Ltd F:KOS1	US
C	Cherat Packaging Ltd KAR:CPPL	PK
K	KB No.25 Special Purpose Acquisition Co KOSDAQ:455250	KR
A	Aeroporto Guglielmo Marconi di Bologna SpA F:169	IT
D	Ditto (Thailand) PCL SET:DITTO	TH

Profitability Summary

Swedish Orphan Biovitrum AB (publ)'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

77% > 78%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

24%

Operating Margin is Increasing

22% > 31%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

13% > 5%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

22%

ROIC is Increasing

6% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.